About Asmn-Irccs
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Asmn-Irccs
During the past decade, Asmn-Irccs conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Asmn-Irccs
According to Clinical.Site data, the most researched conditions in "Asmn-Irccs" are
"CD20 Positive Diffuse Large B-cell Lymphoma" (1 trials), "Elderly Unfit Patients" (1 trials) and "Non Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Asmn-Irccs" in a lesser frequency.
Clinical Trials Intervention Types at Asmn-Irccs
Most popular intervention types in "Asmn-Irccs" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ga101" (1 trials) and "R-DHAP/R-ICE" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Asmn-Irccs
The vast majority of trials in "Asmn-Irccs" are
2 trials for "All" genders.
Clinical Trials Status at Asmn-Irccs
Currently, there are NaN active trials in "Asmn-Irccs".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Asmn-Irccs,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Asmn-Irccs, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".